Centre has said that it plans to ramp up the production of Bharat Biotech’s Covaxin from 1.5 crore doses to about 10 crore doses every month.
NITI Aayog member Dr VK Paul said, total production of Covaxin doses will be further scaled up to 13 crore doses a month when three public sector undertakings start manufacturing the vaccine.
Briefing media persons, he said that the government will look at more private players to scale up the production of Covaxin.
Haffkine Biopharmaceuticals in Mumbai, Indian Immunologicals in Hyderabad and Bulandshahr-based Bharat Immunologicals and Biologicals are the three public sector units that will manufacture Covaxin vaccine.
Dr Paul said, Bharat Biotech’s vaccine technology is being shared with the three PSUs with a provision of 150-crore rupees funding to scale up production.